Basit öğe kaydını göster

dc.contributor.authorYILMAZ, Yetkin Zeki
dc.contributor.authorBATIOĞLU KARAALTIN, Ayşegül
dc.contributor.authorOzdemir, Yusuf Emre
dc.contributor.authorYilmaz, Begum Bahar
dc.contributor.authorÖZDOĞAN, Hasan Ahmet
dc.contributor.authorÇAKAN, DOĞAN
dc.contributor.authorKARAALİ, RIDVAN
dc.contributor.authorKOCAZEYBEK, Bekir Sami
dc.date.accessioned2021-12-10T10:57:20Z
dc.date.available2021-12-10T10:57:20Z
dc.identifier.citationYILMAZ Y. Z. , Yilmaz B. B. , Ozdemir Y. E. , KOCAZEYBEK B. S. , KARAALİ R., ÇAKAN D., ÖZDOĞAN H. A. , BATIOĞLU KARAALTIN A., "Effects of hypertonic alkaline nasal irrigation on COVID-19", LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2021
dc.identifier.issn2378-8038
dc.identifier.otherav_5e4a5a1e-ac0f-4bab-9274-3f4d117b6670
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/170916
dc.identifier.urihttps://doi.org/10.1002/lio2.686
dc.description.abstractObjective The causative agent of COVID-19 is a novel member of coronaviridaes, SARS-CoV-2. It has been reported that the spike (S) protein of SARS-CoV-2 is responsible of infectivity. The S protein is demonstrated to be inactivated under environmental condition, such as hypertonicity and alkaline pH. The aim of the study was to investigate the effect of hypertonic alkaline nasal irrigation (HANI) on SARS-CoV-2. Methods Sixty patients divided into two groups. The patients in Group 1 used hydroxychloroquine (HCQ), and the patients in Group 2 used HCQ and HANI. Nasopharyngeal samples were collected at the beginning, on 3rd and 7th day of the PCR test positivity. The nasopharyngeal viral load (NVL) changes analyzed with quantitative PCR. Results NVL decrease in weekly period was statistically significant for both groups, when the difference between NVL day 0 and 3rd in Group 1 and NVL difference between day 0 and 3rd in Group 2 were compared. The difference between Groups 1 and 2 in terms of NVL change was statistically significant (P < 0.05). Conclusion We demonstrated a significant decrease in nasopharyngeal SARS-CoV-2 load with HANI solution and suggest that HANI may be promising modality for the COVID-19 treatment. Level of evidence IB
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectCerrahi Tıp Bilimleri
dc.subjectKulak Burun Boğaz
dc.subjectOtorhinolaryngology
dc.subjectSpeech and Hearing
dc.subjectKlinik Tıp
dc.subjectKULAK BURUN BOĞAZ
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.titleEffects of hypertonic alkaline nasal irrigation on COVID-19
dc.typeMakale
dc.relation.journalLARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Cerrahi Tıp Bilimleri Bölümü
dc.contributor.firstauthorID2772215


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster